-
Israel Cancer Research Fund Partners with The Mark Foundation for Cancer Research to Support Lung Cancer Project Grant at Weizmann Institute of Science
25 Sep 2025 13:48 GMT
… lung cancer who urgently need better options."
Lung cancer … yet been evaluated for lung cancer. These innovative, engineered … advances in lung cancer treatment for humans.
"Lung cancer remains … , where he developed Herceptin, a targeted therapy …
-
FDA Grants Accelerated Approval to First Oral Targeted Therapy for HER2-Mutant Lung Cancer
15 Aug 2025 02:42 GMT
… treated adults with advanced lung cancer driven by HER2 mutations. … 4% of non-small cell lung cancers (NSCLC) and are … breast cancer; the FDA approved Herceptin (trastuzumab) in 1998. … gastric, biliary tract and lung cancer.
Hernexeos is indicated to …
-
Ensuring Coverage of Faster Biomarker Testing in Lung Cancer: Robert Kratzke, MD
16 Jul 2025 00:21 GMT
… patients with non–small cell lung cancer (NSCLC) can lead … advancements in precision medicine in lung cancer.
This transcript was lightly … all of our patients with lung cancer.
AJMC: What role … Drugs such as trastuzumab (Herceptin) are now commonly accepted …
-
Dr Mark Porter: I’ve got something positive to tell you about cancer
11 Nov 2025 01:15 GMT
… Willson’s death from lung cancer and Davina McCall’s … , like the older trastuzumab (Herceptin) in breast cancer, work … that has already happened with Herceptin.
Last, but not least, … biopsy in others (like lung cancer) to determine tumour characteristics …
-
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q3 2025 Earnings Call Transcript
06 Nov 2025 13:27 GMT
… extensive stage small cell lung cancer. Both therapies are now … extensive stage small cell lung cancer.
Data from the Phase … in frontline small cell lung cancer, completely changed paradigm and … question is zanidatamab versus Herceptin. And then to your …
-
United States Oncology Biosimilars Market is expected to reach US$ 30.83 Billion by 2033 | DataM Intelligence
04 Nov 2025 13:46 GMT
… breast, colorectal, and lung cancer. Regionally, Europe holds … key biologic drugs like Herceptin, Avastin, and … regimens. Biosimilars of Trastuzumab (Herceptin), Bevacizumab (Avastin), and … Other major segments include lung cancer, colorectal cancer, and …
-
<![CDATA[Oncology Experts Dive Into Top Data From ESMO 2025]]>
04 Nov 2025 04:04 GMT
… (Enhertu) plus a taxane, trastuzumab (Herceptin), and pertuzumab (Perjeta; THP) improved … -Huang Center for EGFR Mutant Lung Cancers, senior physician, and the David … with advanced non–small cell lung cancer.
Andrea Necchi, MD, an associate …
-
Proposal To Fund Medicines For Lung Cancer, Breast Cancer And Respiratory Conditions
13 Sep 2024 00:42 GMT
… of advanced non-small-cell lung
cancer:
as a first treatment option …
since the emergence of trastuzumab (Herceptin) 20 years
ago."
Chair … .
Proposal
to fund treatments for lung cancer, breast cancer and
respiratory
conditions …
-
<![CDATA[October 2025: A Look at FDA Oncology Approvals and Designations]]>
02 Nov 2025 20:03 GMT
… for extensive-stage small cell lung cancer (ES-SCLC) and an adjuvant … ) followed by paclitaxel (Taxol), trastuzumab (Herceptin), and pertuzumab (Perjeta; THP) for …
-
[Latest] Global Lung Tumor Market Size/Share Worth USD 46.3 Billion by 2033 at a 7.7% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
15 Apr 2024 16:30 GMT
… lung tumor diagnosis. This delay could result in the diagnosis of lung tumors … Related Reports: Lung Cancer Liquid Biopsy Market: Lung Cancer Liquid Biopsy … (Avastin), Rituximab (Rituxan), Trastuzumab (Herceptin), Cetuximab (Erbitux), Panitumumab (Vectibix), …
About
© 1995-2025